In a new paper, a team from Yale and Fred Hutch has found autoantibody reactivity could predict cancer patients' response to ...

While current treatments for schizophrenia—a mental illness affecting 1% of the world's population—can reduce certain ...

VISTA, an AI-controlled data loop system, guides large-scale antibody design from scratch for applications in cancer therapy.

Infinimmune’s AI Model GLIMPSE-1 Engineers Human-Sourced Antibodies The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies North American and African clinical trials led by Scripps Research, IAVI and additional collaborators ...

ProBio will showcase pre-clinical in vitro and in vivo data demonstrating the potential of its innovative CD3 agonistic single-domain antibody (sdAb/VHH) as a foundational component for advancing the ...

Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, offering a dual-targeting strategy to enhance the therapeutic efficacy of monoclonal antibodies, which is often limited by ...

Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles.

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19 ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

Monoclonal antibodies are a type of synthetic, human-made, antibody. They work similarly to antibodies that the body naturally produces, binding only to specific antigens.